LIPO-Liposome Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LIPO-Liposome

LIPO 0.288

+68.4%

Jan 30 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ed who wrote (697)	6/9/1999 2:05:00 PM
From: Cheeseburger	Read Replies (3) of 900

LIPO is in the June issue of Standard and Poor's newsletter. Page 5 of the newsletter reads: "All of the issues appraised below carry Standard & Poor's highest STARS ranking for superior appreciation potential..." One of those named companies is "The Liposome Company". The coloumn written about LIPO reads: "...we think Liposome is a prime example of the type of biopharmaceutical company that should attract investor attention: a firm with late-stage or currently marketed products entering large markets where therapeutic improvements are needed. With $57 million in cash, it possesses the critical funding to develop its existing drug pipeline and license new products. Companies with such products become prime acquisition targets for large pharmaceutical firms with dwindling drug development pipelines and products about to come off patent...with solid management, a proven technology platform and favorable news expected, the shares have significant upside potential.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next